Analysis

IntegrativePractitioner.com industry analysis and commentary. Views expressed are of the authors only.

May 8, 2023

The World Health Organization (WHO) declared an end to its designation of COVID-19 as a global health emergency on Friday.

Due to a decreasing trend

Read More
May 5, 2023

 

Attention Deficit Hyperactivity Disorder (ADHD) affects an estimated 9-13% of kids and 8% of adults in the U.S. each year. There is an

Read More
May 4, 2023

The Integrative Healthcare Symposium (IHS) is accepting proposals to present at the 2024 Integrative Healthcare Symposium, which will be

Read More
May 3, 2023

The National Center for Complementary and Integrative Health (NCCIH) and the National Institute on Aging (NIA) recently announced a new web-based

Read More
May 2, 2023

Robert Rountree, MD, joins Integrative Practitioner associate editor, Avery St. Onge, to discuss the different causes of irritable bowel syndrome,

Read More
May 2, 2023

Semaglutide, tradename Ozempic, is an injectable drug that people with type 2 diabetes take weekly to control their blood sugar levels. It also

Read More
May 2, 2023
Integrative Health Symposium
Price: $350.00
Free for Gold Members
Add to Cart

Integrative Practitioner is pleased to offer the Complete Conference Package, featuring

Read More
May 2, 2023

Join Betsy Redmond, Ph.D., MMSc, RDN, on June 15 at 2 PM ET as she explains how to use the OMX™ Organic Metabolomics profile to identify

Read More